rs906755254
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PVS1PP5_Very_Strong
The NM_000124.4(ERCC6):c.2839C>T(p.Arg947*) variant causes a stop gained change. The variant allele was found at a frequency of 0.0000143 in 1,613,768 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000124.4 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000395 AC: 6AN: 152030Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000399 AC: 1AN: 250858Hom.: 0 AF XY: 0.00000738 AC XY: 1AN XY: 135558
GnomAD4 exome AF: 0.0000116 AC: 17AN: 1461738Hom.: 0 Cov.: 32 AF XY: 0.0000110 AC XY: 8AN XY: 727180
GnomAD4 genome AF: 0.0000395 AC: 6AN: 152030Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74252
ClinVar
Submissions by phenotype
not provided Pathogenic:4
This sequence change creates a premature translational stop signal (p.Arg947*) in the ERCC6 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ERCC6 are known to be pathogenic (PMID: 18628313, 29572252). This variant is present in population databases (no rsID available, gnomAD 0.02%). This premature translational stop signal has been observed in individual(s) with Cockayne syndrome (PMID: 29572252). ClinVar contains an entry for this variant (Variation ID: 502165). For these reasons, this variant has been classified as Pathogenic. -
- -
- -
- -
Cerebrooculofacioskeletal syndrome 1;C0265201:DE SANCTIS-CACCHIONE SYNDROME;C0751038:Cockayne syndrome type 2 Pathogenic:1
- -
Cerebrooculofacioskeletal syndrome 1;C0242379:Lung cancer;C0265201:DE SANCTIS-CACCHIONE SYNDROME;C0751038:Cockayne syndrome type 2;C3151063:Age related macular degeneration 5;C3551173:UV-sensitive syndrome 1;C4310783:Premature ovarian failure 11 Pathogenic:1
- -
Cockayne syndrome type 2 Pathogenic:1
The observed stop gained c.2839C>Tp.Arg947Ter variant in ERCC6 gene has been reported previously in homozygous and compound heterozygous states in individuals affected with Cockayne syndrome Calmels N, et al., 2018; Duong NT, et al., 2022. The c.2839C>T variant is present with 0.0004% in gnomAD Exomes. This variant has been submitted to the ClinVar database as Likely Pathogenic / Pathogenic. The nucleotide change c.2839C>T in ERCC6 is predicted as conserved by GERP++ and PhyloP across 100 vertebrates. This sequence change creates a premature translational stop signal p.Arg947Ter in the ERCC6 gene. This variant is predicted to cause loss of normal protein function through protein truncation. Loss of function variants have been previously reported to be disease causing Calmels N, et al., 2018. For these reasons, this variant has been classified as Pathogenic. In absence of another reportable variant in ERCC6 gene, the molecular diagnosis is not confirmed. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at